ASTRAZENECA PLC reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cambridge
SEC filing record 1 source field available
Fiscal year end
31 December
ASTRAZENECA PLC has filed 2,050 SEC EDGAR filings since 13 Mar 1995

SEC filing history

Showing 601-625 of 1,000 matching filings.

Per page
25
Current page
25
6-K File 001-11960

BOARD COMMITTEE CHANGE

Filing date
23 Sep 2021
Reporting date
23 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

NEW SUSTAINABILITY COMMITTEE OF THE BOARD

Filing date
23 Sep 2021
Reporting date
23 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

ASTRAZENECA $360M IRISH MANUFACTURING INVESTMENT

Filing date
21 Sep 2021
Reporting date
21 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

ENHERTU REDUCED RISK OF DISEASE PROGRESSION BY 72%

Filing date
20 Sep 2021
Reporting date
20 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

IMFINZI IMPROVES SURVIVAL IN NSCLC IN POSEIDON

Filing date
09 Sep 2021
Reporting date
09 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

FIXED-DOSE COMBINATION OF ALBUTEROL AND BUDESONIDE (PT027) DEMONSTRATED SIGNIFIC

Filing date
09 Sep 2021
Reporting date
09 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

ULTOMIRIS APPROVED IN EU FOR CHILDREN WITH PNH

Filing date
03 Sep 2021
Reporting date
03 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

TOTAL VOTING RIGHTS

Filing date
01 Sep 2021
Reporting date
01 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

FORXIGA APPROVED IN JAPAN FOR CKD

Filing date
26 Aug 2021
Reporting date
26 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

ALXN1840 WILSON PHASE III MET PRIMARY ENDPOINT

Filing date
26 Aug 2021
Reporting date
26 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

UPDATE ON ULTOMIRIS PHASE III ALS TRIAL

Filing date
20 Aug 2021
Reporting date
20 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

AZD7442 PROPHYLAXIS TRIAL MET PRIMARY ENDPOINT

Filing date
20 Aug 2021
Reporting date
20 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

DIRECTOR/PDMR SHAREHOLDING

Filing date
16 Aug 2021
Reporting date
16 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

UPDATE ON US REVIEW OF ROXADUSTAT

Filing date
11 Aug 2021
Reporting date
11 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

FORXIGA APPROVED IN THE EU FOR CKD

Filing date
09 Aug 2021
Reporting date
09 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

ENHERTU HEAD-TO-HEAD TRIAL MEETS PRIMARY ENDPOINT

Filing date
09 Aug 2021
Reporting date
09 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

TOTAL VOTING RIGHTS

Filing date
02 Aug 2021
Reporting date
02 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

SAPHNELO APPROVED IN THE US FOR SLE

Filing date
02 Aug 2021
Reporting date
02 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K/A File 001-11960

FORM 6-K/A

Filing date
30 Jul 2021
Reporting date
30 Jun 2021
Next action
Verify source filing
SC 13G

SC 13G

Filing date
27 Jul 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

ULTOMIRIS RECOMMENDED IN EU FOR CHILDREN WITH PNH

Filing date
26 Jul 2021
Reporting date
26 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

DIRECTORATE CHANGE

Filing date
22 Jul 2021
Reporting date
22 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

FORM 6-K

Filing date
21 Jul 2021
Reporting date
21 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

DIRECTOR/PDMR SHAREHOLDING

Filing date
21 Jul 2021
Reporting date
21 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .